90
80
70
60 1
50
40
30
20
10
00
DAY 1
There was no significant difference between the groups in FEV1 increase as well:
+9.0±6.0% pred. in the Study Simeox group and + 8.0 ± 2.9 % pred. in the Control group (р=0.751) (Fig.1)
Fig.1 FEV1 changes (%pred) in the Study group (blue) and the Control group (green) after 5-day course of treatment.
2 3 4 5 6 7 8 9 10
DAY 5
FEV1 %
15